Compare ALTI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ALTI | SMTI |
|---|---|---|
| Founded | 2020 | 1982 |
| Country | United States | United States |
| Employees | 490 | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.9M | 322.2M |
| IPO Year | 2021 | 2008 |
| Metric | ALTI | SMTI |
|---|---|---|
| Price | $1.48 | $32.72 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 287.8K | 59.0K |
| Earning Date | 11-09-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 41.11 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $254,956,000.00 | $15,586,976.00 |
| Revenue This Year | $17.39 | $11.81 |
| Revenue Next Year | $9.19 | $12.75 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | 23.21 | ★ 32.47 |
| 52 Week Low | $1.25 | $16.05 |
| 52 Week High | $5.45 | $35.52 |
| Indicator | ALTI | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 30.50 | 47.34 |
| Support Level | $1.25 | $30.40 |
| Resistance Level | $3.97 | $34.90 |
| Average True Range (ATR) | 0.29 | 0.98 |
| MACD | -0.06 | 0.15 |
| Stochastic Oscillator | 12.17 | 85.03 |
AlTi Global Inc is a wealth and investment partner to families, foundations, and institutions, helping clients activate capital, bring structure to complexity, and plan across borders and generations. The company combines the breadth of an international firm with the service offering of a family office to deliver solutions for wealth and capital. It provides services including discretionary and non-discretionary investment advisory, estate and wealth planning, trust and fiduciary, governance, philanthropy, and family office services, along with access to alternative investment opportunities. The company generates revenue from management, advisory, trustee, or administration fees, performance or incentive fees, distributions from investments, and other income or fees.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.